The Campbell’s Company (NASDAQ:CPB – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as $19.70 and last traded at $19.8560, with a volume of 1506450 shares traded. The stock had previously closed at $20.21.
Wall Street Analysts Forecast Growth
Several research firms have weighed in on CPB. Royal Bank Of Canada lowered their target price on shares of Campbell’s from $30.00 to $26.00 and set a “sector perform” rating for the company in a research note on Thursday, March 12th. Bank of America lowered their target price on shares of Campbell’s from $26.00 to $23.00 and set an “underperform” rating for the company in a research note on Thursday, March 12th. UBS Group lowered their target price on shares of Campbell’s from $24.00 to $20.00 and set a “sell” rating for the company in a research note on Friday, March 13th. Wells Fargo & Company lowered shares of Campbell’s from an “equal weight” rating to an “underweight” rating and lowered their target price for the company from $20.00 to $18.00 in a research note on Wednesday, April 8th. Finally, Morgan Stanley lowered their target price on shares of Campbell’s from $25.00 to $23.00 and set an “equal weight” rating for the company in a research note on Thursday, April 23rd. One analyst has rated the stock with a Buy rating, fourteen have given a Hold rating and seven have assigned a Sell rating to the company. According to MarketBeat, Campbell’s presently has a consensus rating of “Reduce” and an average target price of $26.06.
Check Out Our Latest Stock Report on CPB
Campbell’s Stock Down 0.2%
Campbell’s (NASDAQ:CPB – Get Free Report) last released its quarterly earnings results on Wednesday, March 11th. The company reported $0.51 EPS for the quarter, missing the consensus estimate of $0.57 by ($0.06). The firm had revenue of $2.56 billion for the quarter. Campbell’s had a return on equity of 19.96% and a net margin of 5.48%.The business’s revenue was down 4.5% on a year-over-year basis. During the same period in the prior year, the company earned $0.74 EPS. Campbell’s has set its FY 2026 guidance at 2.150-2.250 EPS. As a group, research analysts expect that The Campbell’s Company will post 2.19 earnings per share for the current year.
Campbell’s Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Monday, August 3rd. Stockholders of record on Thursday, July 2nd will be given a dividend of $0.39 per share. The ex-dividend date is Thursday, July 2nd. This represents a $1.56 annualized dividend and a dividend yield of 7.7%. Campbell’s’s dividend payout ratio is currently 85.25%.
Hedge Funds Weigh In On Campbell’s
Several institutional investors have recently modified their holdings of CPB. Stance Capital LLC acquired a new stake in Campbell’s in the third quarter worth about $27,000. Flagship Harbor Advisors LLC acquired a new stake in Campbell’s in the fourth quarter worth about $29,000. Sittner & Nelson LLC acquired a new stake in Campbell’s in the fourth quarter worth about $29,000. Los Angeles Capital Management LLC acquired a new stake in Campbell’s in the fourth quarter worth about $29,000. Finally, Ankerstar Wealth LLC acquired a new stake in Campbell’s in the fourth quarter worth about $29,000. Institutional investors own 52.35% of the company’s stock.
About Campbell’s
Campbell’s (NASDAQ: CPB) is a leading manufacturer of shelf-stable foods and beverages, best known for its iconic soups and broths. Headquartered in Camden, New Jersey, the company offers a diverse portfolio of products designed to meet consumer demand for convenient, affordable meals and snacks. Since its founding in 1869, Campbell’s has grown through a combination of organic innovation and strategic acquisitions to expand its presence in the food industry.
The company’s brand portfolio includes Campbell’s Condensed Soups, V8 juices, Prego pasta sauces, Swanson broths and stocks, Pace salsas and dips, and Pepperidge Farm baked snacks.
Read More
- Five stocks we like better than Campbell’s
- 3 Space Infrastructure Stocks Gaining Momentum Ahead of the SpaceX IPO
- The Great AI Rotation: Cashing In on Data
- Mirum Pharma: A Rare Disease Growth Story to Watch
- The Great Cloud Divide: How AI Is Reshuffling the Software Deck
Receive News & Ratings for Campbell's Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Campbell's and related companies with MarketBeat.com's FREE daily email newsletter.
